SBIO vs. AMLP
SBIO (ALPS Medical Breakthroughs ETF) and AMLP (Alerian MLP ETF) are both exchange-traded funds - SBIO is a Health & Biotech Equities fund tracking the S-Network Medical Breakthroughs Index, while AMLP is a MLPs fund tracking the Alerian MLP Infrastructure Index. Both are passively managed. Over the past 10 years, SBIO returned 8.03%/yr vs 6.74%/yr for AMLP. At a 0.28 correlation, their price movements are largely independent. SBIO charges 0.50%/yr vs 0.90%/yr for AMLP.
Performance
SBIO vs. AMLP - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SBIO achieves a 1.95% return, which is significantly lower than AMLP's 17.77% return. Over the past 10 years, SBIO has outperformed AMLP with an annualized return of 8.03%, while AMLP has yielded a comparatively lower 6.74% annualized return.
SBIO
- 1D
- 2.35%
- 1M
- -5.55%
- YTD
- 1.95%
- 6M
- 4.13%
- 1Y
- 68.86%
- 3Y*
- 18.38%
- 5Y*
- 3.16%
- 10Y*
- 8.03%
AMLP
- 1D
- 1.25%
- 1M
- 0.71%
- YTD
- 17.77%
- 6M
- 15.18%
- 1Y
- 20.38%
- 3Y*
- 20.70%
- 5Y*
- 17.19%
- 10Y*
- 6.74%
SBIO vs. AMLP - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SBIO ALPS Medical Breakthroughs ETF | 1.95% | 55.07% | 3.81% | 8.68% | -28.08% | -17.55% | 21.17% | 50.30% | -11.81% | 45.67% |
AMLP Alerian MLP ETF | 17.77% | 5.78% | 22.76% | 21.40% | 25.47% | 39.09% | -32.26% | 5.99% | -12.67% | -7.89% |
Correlation
The correlation between SBIO and AMLP is -0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.03 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.26 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.29 |
Correlation (All Time) Calculated using the full available price history since Jan 2, 2015 | 0.28 |
The correlation between SBIO and AMLP shifts across timeframes, from -0.03 (1 year) to 0.29 (10 years), reflecting how their relationship changes across market environments.
SBIO vs. AMLP - Sectors Allocation Comparison
Sectors
SBIO
AMLP
Healthcare
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
Financial Services
-
Healthcare
SBIO
AMLP
-
Basic Materials
SBIO
-
AMLP
-
Communication Services
SBIO
-
AMLP
-
Consumer Cyclical
SBIO
-
AMLP
-
Consumer Defensive
SBIO
-
AMLP
-
Energy
SBIO
-
AMLP
Industrials
SBIO
-
AMLP
-
Real Estate
SBIO
-
AMLP
-
Technology
SBIO
-
AMLP
-
Utilities
SBIO
-
AMLP
Financial Services
SBIO
AMLP
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SBIO vs. AMLP — Risk / Return Rank
SBIO
AMLP
SBIO vs. AMLP - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ALPS Medical Breakthroughs ETF (SBIO) and Alerian MLP ETF (AMLP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SBIO | AMLP | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.61 | ||
| Sortino ratioReturn per unit of downside risk | +0.80 | ||
| Omega ratioGain probability vs. loss probability | 1.38 | 1.30 | +0.07 |
| Calmar ratioReturn relative to maximum drawdown | 5.47 | 2.29 | +3.18 |
| Martin ratioReturn relative to average drawdown | 16.23 | 7.60 | +8.63 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| SBIO | AMLP | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.35 | 1.74 | +0.61 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.09 | 0.86 | -0.77 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.24 | 0.24 | 0.00 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.22 | 0.23 | -0.01 |
Drawdowns
SBIO vs. AMLP - Drawdown Comparison
The maximum SBIO drawdown since its inception was -63.06%, smaller than the maximum AMLP drawdown of -77.19%. Use the drawdown chart below to compare losses from any high point for SBIO and AMLP.
Loading charts...
Drawdown Indicators
| SBIO | AMLP | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -63.06% | -77.19% | +14.13% |
Max Drawdown (1Y)Largest decline over 1 year | -12.66% | -8.94% | -3.72% |
Max Drawdown (3Y)Largest decline over 3 years | -42.44% | -14.27% | -28.17% |
Max Drawdown (5Y)Largest decline over 5 years | -53.10% | -20.92% | -32.18% |
Max Drawdown (10Y)Largest decline over 10 years | -63.06% | -72.62% | +9.56% |
Current DrawdownCurrent decline from peak | -14.84% | -2.90% | -11.94% |
Average DrawdownAverage peak-to-trough decline | -28.44% | -17.40% | -11.04% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.26% | 2.69% | +1.57% |
Volatility
SBIO vs. AMLP - Volatility Comparison
ALPS Medical Breakthroughs ETF (SBIO) has a higher volatility of 9.85% compared to Alerian MLP ETF (AMLP) at 5.08%. This indicates that SBIO's price experiences larger fluctuations and is considered to be riskier than AMLP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SBIO | AMLP | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.85% | 5.08% | +4.77% |
Volatility (6M)Calculated over the trailing 6-month period | 22.76% | 8.65% | +14.11% |
Volatility (1Y)Calculated over the trailing 1-year period | 29.40% | 11.88% | +17.52% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.57% | 19.99% | +13.58% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.18% | 27.67% | +5.51% |
SBIO vs. AMLP - Expense Ratio Comparison
SBIO has a 0.50% expense ratio, which is lower than AMLP's 0.90% expense ratio.
Dividends
SBIO vs. AMLP - Dividend Comparison
SBIO has not paid dividends to shareholders, while AMLP's dividend yield for the trailing twelve months is around 7.55%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AMLP Alerian MLP ETF | 7.55% | 8.36% | 7.70% | 7.86% | 7.70% | 8.55% | 12.31% | 9.12% | 9.29% | 7.97% | 8.09% | 9.84% |
SBIO ALPS Medical Breakthroughs ETF | 0.00% | 0.00% | 3.55% | 0.22% | 0.00% | 0.00% | 0.00% | 0.04% | 2.79% | 1.77% | 0.00% | 0.00% |
Frequently Asked Questions
SBIO and AMLP have a correlation of -0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SBIO has higher volatility (9.85%) compared to AMLP (5.08%). In terms of maximum drawdown, SBIO dropped -63.06% vs AMLP's -77.19%.
On 10-year performance, SBIO leads with 8.03% vs 6.74% for AMLP. On fees, SBIO is cheaper at 0.50% per year. On volatility, AMLP has been the lower-risk option at 5.08%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, SBIO has performed better with a 8.03% return vs 6.74%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
SBIO is cheaper with a 0.50% expense ratio, compared with 0.90% for AMLP.
AMLP has the higher dividend yield at 7.55%, compared with 0.00% for SBIO.
SBIO is categorized as Health & Biotech Equities, while AMLP is MLPs. SBIO tracks S-Network Medical Breakthroughs Index, while AMLP tracks Alerian MLP Infrastructure Index. Their fees differ too: 0.50% for SBIO and 0.90% for AMLP.
SBIO currently has the higher Sharpe Ratio (2.35 vs 1.74), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SBIO and AMLP
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer